BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7741305)

  • 1. Human plasma cholinesterase for antagonism of prolonged mivacurium-induced neuromuscular blockade.
    Naguib M; el-Gammal M; Daoud W; Ammar A; Moukhtar H; Turkistani A
    Anesthesiology; 1995 May; 82(5):1288-92. PubMed ID: 7741305
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of intense mivacurium block with human plasma cholinesterase in patients with atypical plasma cholinesterase.
    Ostergaard D; Jensen FS; Viby-Mogensen J
    Anesthesiology; 1995 May; 82(5):1295-8. PubMed ID: 7741307
    [No Abstract]   [Full Text] [Related]  

  • 3. Enzymatic antagonism of mivacurium-induced neuromuscular blockade by human plasma cholinesterase.
    Naguib M; Daoud W; el-Gammal M; Ammar A; Turkistani A; Selim M; Altamimi W; Sohaibani MO
    Anesthesiology; 1995 Oct; 83(4):694-701. PubMed ID: 7574048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic versus pharmacologic antagonism of profound mivacurium- induced neuromuscular blockade.
    Naguib M; Selim M; Bakhamees HS; Samarkandi AH; Turkistani A
    Anesthesiology; 1996 May; 84(5):1051-9. PubMed ID: 8623998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of edrophonium and neostigmine for the reversal of mivacurium-induced neuromuscular blockade in sheep.
    Clutton RE; Glasby MA
    Res Vet Sci; 1998; 64(3):265-6. PubMed ID: 9690616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Edrophonium increases mivacurium concentrations during constant mivacurium infusion, and large doses minimally antagonize paralysis.
    Hart PS; Wright PM; Brown R; Lau M; Sharma ML; Miller RD; Gruenke L; Fisher DM
    Anesthesiology; 1995 Apr; 82(4):912-8. PubMed ID: 7717563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can succinylcholine antagonize mivacurium-induced neuromuscular block?
    Baraka A
    Anesth Analg; 1996 Jul; 83(1):200-1. PubMed ID: 8659753
    [No Abstract]   [Full Text] [Related]  

  • 8. Edrophonium and human plasma cholinesterase combination for antagonism of mivacurium-induced neuromuscular block.
    Naguib M; Samarkandi AH; Bakhamees HS; Turkistani A; Alharby SW
    Br J Anaesth; 1996 Sep; 77(3):424-6. PubMed ID: 8949825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma cholinesterase variations as a result of prolonged neuromuscular blockade. Review and problems encountered in two cases of prolonged neuromuscular blockade after muscle relaxation with succinylcholine as compared to mivacurium].
    Lang C; Lukasewitz P; Wulf H; Geldner G
    Anaesthesist; 2002 Feb; 51(2):134-41. PubMed ID: 11963306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block.
    Beaufort TM; Nigrovic V; Proost JH; Houwertjes MC; Wierda JM
    Anesthesiology; 1998 Sep; 89(3):707-14. PubMed ID: 9743409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency.
    Goudsouzian NG; d'Hollander AA; Viby-Mogensen J
    Anesth Analg; 1993 Jul; 77(1):183-5. PubMed ID: 8317728
    [No Abstract]   [Full Text] [Related]  

  • 12. Potentiation of mivacurium blockade by low dose of pancuronium: a pharmacokinetic study.
    Motamed C; Menad R; Farinotti R; Kirov K; Combes X; Bouleau D; Feiss P; Duvaldestin P
    Anesthesiology; 2003 May; 98(5):1057-62. PubMed ID: 12717125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged mivacurium-induced neuromuscular block.
    Bevan DR
    Anesth Analg; 1993 Jul; 77(1):4-6. PubMed ID: 8317744
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel pharmacological approaches for the antagonism of neuromuscular blockade.
    Pic LC
    AANA J; 2005 Feb; 73(1):37-40. PubMed ID: 15727282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia.
    Frampton JE; McTavish D
    Drugs; 1993 Jun; 45(6):1066-1089. PubMed ID: 7691494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged neuromuscular block associated with mivacurium.
    Fox MH; Hunt PC
    Br J Anaesth; 1995 Feb; 74(2):237-8. PubMed ID: 7696077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neostigmine but not edrophonium prolongs the action of mivacurium.
    Symington MJ; Mirakhur RK; Kumar N
    Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged neuromuscular block after mivacurium.
    Petersen RS; Bailey PL; Kalameghan R; Ashwood ER
    Anesth Analg; 1993 Jan; 76(1):194-6. PubMed ID: 8418724
    [No Abstract]   [Full Text] [Related]  

  • 19. Antagonism of residual mivacurium blockade: setting the record straight.
    Savarese JJ; Lien CA; Belmont MR
    Anesthesiology; 1996 Jun; 84(6):1525-8. PubMed ID: 8669705
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mivacurium].
    Ortiz JR; Carrascosa F
    Rev Esp Anestesiol Reanim; 1997 Oct; 44(8):315-20. PubMed ID: 9424685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.